(Q37015711)

17 August 2017

Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil (English)

1 reference

17 August 2017

0 references

0 references

0 references

Antonio G Pacheco

5

0 references

Lawrence H. Moulton

object named as

Lawrence H Moulton

6

0 references

Valeria Saraceni

9

object named as

Valeria Saraceni

1 reference

17 August 2017

8

Richard E Chaisson

1 reference

17 August 2017

Jonathan E Golub

1

1 reference

17 August 2017

Betina Durovni

2

1 reference

17 August 2017

Bonnie S King

3

1 reference

17 August 2017

Solange C Cavalacante

4

1 reference

17 August 2017

Richard D Moore

7

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

17 August 2017

1 reference

17 August 2017

22

1 reference

17 August 2017

18

1 reference

17 August 2017

2527-2533

1 reference

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Factors associated with drug resistance in pulmonary tuberculosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Short term chemotherapy of tuberculosis. Factors affecting relapse following short term chemotherapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

The impact of HIV infection on recurrence of tuberculosis in South African gold miners

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Isoniazid plus sulphadoxine-pyrimethamine can reduce morbidity of HIV-positive patients treated for tuberculosis in Africa: a controlled clinical trial.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2603140

HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group

4 December 2018

1 reference

12 December 2020

Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil

1 reference

12 December 2020

Recommendations of the Interim Policy on Collaborative TB/HIV activities

1 reference

12 December 2020

Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy

1 reference

12 December 2020

Why pulmonary tuberculosis recurs: a population-based epidemiological study

1 reference

12 December 2020

Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil

1 reference

12 December 2020

Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk

1 reference

12 December 2020

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa

1 reference

12 December 2020

Recurrent tuberculosis: why do patients develop disease again? A United States Public Health Service cooperative survey

1 reference

12 December 2020

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

12 December 2020

A continuing survey of drug-resistant tuberculosis, New York City, April 1994

1 reference

12 December 2020

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

1 reference

12 December 2020

10.1097/QAD.0B013E328311AC4E

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

1 reference